---
title: "晶泰控股有限公司 (02228.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/02228.HK.md"
symbol: "02228.HK"
name: "晶泰控股有限公司"
industry: "生命科学工具与服务"
---

# 晶泰控股有限公司 (02228.HK)

| Item | Detail |
|------|--------|
| Industry | 生命科学工具与服务 |
| Location | 港股市场 |
| Website | [www.xtalpi.com](https://www.xtalpi.com) |

## Company Profile

晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务主要包括早期苗头化合物生成到研究性新药的开发阶段，为临床试验的启动提供研究。智能机器人解决方案主要包括固态研发服务及自动化化学合成服务等。该公司在国内和国外市场开展业务。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:13.000Z

**Overall: B (0.39)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 4 / 14 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 246.00% |  |
| Net Profit YoY | 92.24% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 6.31 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 48.41B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 738.33M |  |


**Multi Score**: B

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -3.54% | D |
| Profit Margin | -28.90% | E |
| Gross Margin | 84.15% | A |

#### Growth Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 246.00% | A |
| Net Profit YoY | 92.24% | A |
| Total Assets YoY | 76.17% | A |
| Net Assets YoY | 72.87% | A |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -345.98% | D |
| OCF YoY | 246.00% | A |

#### Operating Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.11 | E |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 8.93% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 晶泰控股有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-3.54%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-28.90%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "84.15%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "A",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "246.00%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "92.24%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "76.17%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "72.87%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-345.98%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "246.00%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "E",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.11",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "8.93%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 药明康德 (HK.2359) | A | A | C | B | B | B |
| 02 | 药明生物 (HK.2269) | B | B | D | A | B | B |
| 03 | 药明合联 (HK.2268) | A | A | B | B | B | B |
| 04 | 晶泰控股 (HK.2228) | D | A | E | A | C | B |
| 05 | 康龙化成 (HK.3759) | B | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -224.35 | 15/15 | - | - | - |
| PB | 6.31 | 13/15 | 6.51 | 5.69 | 5.12 |
| PS (TTM) | 64.84 | 14/15 | 84.95 | 67.54 | 60.50 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-07T16:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 4 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 11.25 |
| Highest Target | 12.40 |
| Lowest Target | 7.57 |

## References

- [Company Overview](https://longbridge.com/en/quote/02228.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/02228.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/02228.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.